🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Tuberculosis (TB) continues to be one of the most serious bacterial infecti...
Status
Completed
Location
Primecure Medicentre, Mercantile Hospital
Start Date
2012-09
Trial ID
NCT01642888
Treatments Being Tested
The aim of this study is to investigate the mechanisms behind the immune dy...
Status
Withdrawn
Location
Royal Free London NHS Foundation Trust
Start Date
2014-05
Trial ID
NCT02102841
Treatments Being Tested
The purpose of this research study is to find out if giving the smaller dos...
Status
Completed
Location
Saint Louis University
Start Date
2005-11
Trial ID
NCT00253734
Treatments Being Tested
The investigators will contact 64 patients with atopic dermatitis (AD) who ...
Status
Completed
Location
Skin- and Allergy Hospital, Department of Dermatology
Start Date
2008-11
Trial ID
NCT00795496
Treatments Being Tested
The primary objective is to assess the safety of two doses of C-Tb (0.01 an...
Status
Completed
Location
St George's University of London
Start Date
2010-01
Trial ID
NCT01033929
Treatments Being Tested
Treatment of a wide range of diseases using stem cells and other types of c...
Status
Completed
Location
University of Edinburgh / Royal Infirmary of Edinburgh
Start Date
2010-07
Trial ID
NCT01169935
Silicosis, a preventable yet irreversible occupational lung disease, has an...
Status
Completed
Location
University of Oklahoma Health Sciences Center
Start Date
2019-01-14
Trial ID
NCT04205708
Treatments Being Tested
The study is designed to test the hypothesis that BCG administration via je...
Status
Completed
Location
SATVI, University of Cape Town
Start Date
2012-12
Trial ID
NCT01742364
Treatments Being Tested
In the tests, small sample of clinical study about Recombinant Mycobacteriu...
Status
Completed
Location
Multiple Locations
Start Date
2013-09
Trial ID
NCT01999231
Treatments Being Tested
The primary objective is to assess the safety of three dose levels (0.01, 0...
Status
Completed
Location
Rigshospitalet, Epidemiklinikken
Start Date
2008-11
Trial ID
NCT00793702
Treatments Being Tested